The global spinal cord injury therapeutics market is estimated to be valued at US$ 8.53 Bn in 2024 and is expected to exhibit a CAGR of 14% over the forecast period 2024 to 2031.
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |